Table of Contents Author Guidelines Submit a Manuscript
International Journal of Hypertension
Volume 2014, Article ID 427684, 9 pages
http://dx.doi.org/10.1155/2014/427684
Research Article

The Burden of Blood-Pressure-Related Cardiovascular Mortality in Mexico

1Department of Public Health and Preventive Medicine, School of Medicine and Center for Research and Development on Health Science, Universidad Autónoma de Nuevo Leon, 64460 Monterrey, NL, Mexico
2Department of Preventive Medicine and Public Health, Universidad Autónoma de Madrid/IdiPAZ, CIBER in Epidemiology and Public Health (CIBERESP), 28029 Madrid, Spain
3Institute for Social Research, Center for Research and Development on Health Science, Faculty of Accounting and Business Administration, Universidad Autónoma de Nuevo León, 64460 Monterrey, NL, Mexico

Received 14 October 2013; Accepted 28 December 2013; Published 10 February 2014

Academic Editor: B. Waeber

Copyright © 2014 Dora E. Cortés-Hernández et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Lewington, R. Clarke, N. Qizilbash, R. Peto, and R. Collins, “Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies,” The Lancet, vol. 360, no. 9349, pp. 1903–1913, 2002. View at Publisher · View at Google Scholar · View at Scopus
  2. W. B. Kannel, “Update on hypertension as a cardiovascular risk factor,” in Manual of Hypertension, G. Mancia, J. Chalmers, S. Julius et al., Eds., pp. 3–21, Churchill Livingstone, London, UK, 2002. View at Google Scholar
  3. S. Yusuf, P. Sleight, J. Pogue, J. Bosch, R. Davies, and G. Dagenais, “Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The heart outcomes prevention evaluation atudy investigators,” The New England Journal of Medicine, vol. 342, pp. 145–153, 2000. View at Publisher · View at Google Scholar
  4. J. G. Wang, J. A. Staessen, S. S. Franklin, R. Fagard, and F. Gueyffier, “Systolic and diastolic blood pressure lowering as determinants of cardiovascular outcome,” Hypertension, vol. 45, no. 5, pp. 907–913, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. N. S. Beckett, R. Peters, A. E. Fletcher et al., “Treatment of hypertension in patients 80 years of age or older,” New England Journal of Medicine, vol. 358, no. 18, pp. 1887–1898, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. I. Sipahi, A. Swaminathan, V. Natesan, S. M. Debanne, D. I. Simon, and J. C. Fang, “Effect of antihypertensive therapy on incident stroke in cohorts with prehypertensive blood pressure levels: a meta-analysis of randomized controlled trials,” Stroke, vol. 43, no. 2, pp. 432–440, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. E. Pimenta and S. Oparil, “Prehypertension: epidemiology, consequences and treatment,” Nature Reviews Nephrology, vol. 6, no. 1, pp. 21–30, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. P. M. Kearney, M. Whelton, K. Reynolds, P. Muntner, P. K. Whelton, and J. He, “Global burden of hypertension: analysis of worldwide data,” The Lancet, vol. 365, no. 9455, pp. 217–223, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. C. M. Lawes, S. V. Hoorn, and A. Rodgers, “Global burden of blood-pressure-related disease, 2001,” The Lancet, vol. 371, no. 9623, pp. 1513–1518, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. World Health Organization, Global Status Report on Noncommunicable Diseases 2010. Description of the Global Burden of NCDs, Their Risk Factors and Determinants, World Health Organization, Geneva, Switzerland, 2011.
  11. S. S. Lim, T. Vos, A. D. Flaxman, G. Danaei, K. Shibuya, and H. Adair-Rohani, “A comparative risk assessment of burden of disease andinjury attributable to 67 risk factors and risk factor clustersin 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010,” The Lancet, vol. 380, no. 12, pp. 2224–2260, 2012. View at Publisher · View at Google Scholar
  12. E. Falaschetti, M. Chaudhury, J. Mindell, and N. Poulter, “Continued improvement in hypertension management in England: results from the health survey for England 2006,” Hypertension, vol. 53, no. 3, pp. 480–486, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Wagner, A. Sadoun, J. Dallongeville et al., “High blood pressure prevalence and control in a middle-aged French population and their associated factors: the MONA LISA study,” Journal of Hypertension, vol. 29, no. 1, pp. 43–50, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. B. M. Egan, Y. Zhao, and R. N. Axon, “US trends in prevalence, awareness, treatment, and control of hypertension, 1988–2008,” Journal of the American Medical Association, vol. 303, no. 20, pp. 2043–2050, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. G. Tocci, E. A. Rosei, E. Ambrosioni et al., “Blood pressure control in Italy: analysis of clinical data from 2005–2011 surveys on hypertension,” Journal of Hypertension, vol. 30, no. 6, pp. 1065–1074, 2012. View at Publisher · View at Google Scholar
  16. J. R. Banegas, A. Graciani, J. J. de la Cruz-Troca et al., “Achievement of cardiometabolic goals in aware hypertensive patients in Spain: a nationwide population-based study,” Hypertension, vol. 60, pp. 898–905, 2012. View at Publisher · View at Google Scholar
  17. M. J. Prince, S. Ebrahim, D. Acosta et al., “Hypertension prevalence, awareness, treatment and control among older people in Latin America, India and China: a 10/66 cross-sectional population-based survey,” Journal of Hypertension, vol. 30, no. 1, pp. 177–187, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. G. Stevens, R. H. Dias, K. J. A. Thomas et al., “Characterizing the epidemiological transition in Mexico: National and subnational burden of diseases, injuries, and risk factors,” PLoS Medicine, vol. 5, no. 6, Article ID e125, pp. 900–910, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. Dirección General de Información en Salud (DGIS), Base de Datos de Defunciones GEnerales 1979–2010. [en línea]: Sistema Nacional de Información En Salud (SINAIS), Secretaría de Salud, Mexico City, México, 2012, http://www.sinais.salud.gob.mx.
  20. F. M. Knaul, E. González-Pier, O. Gómez-Dantés et al., “The quest for universal health coverage: achieving social protection for all in Mexico,” The Lancet, vol. 380, no. 9849, pp. 1259–1279, 2012. View at Publisher · View at Google Scholar
  21. S. Barquera, I. Campos-Nonato, L. Hernández-Barrera et al., “Hypertension in mexican adults: results from the National Health and Nutrition Survey 2006,” Salud Publica de Mexico, vol. 52, no. 1, pp. S63–S71, 2010. View at Google Scholar · View at Scopus
  22. I. Campos-Nonato, L. Hernández-Barrera, R. Rojas-Martínez, A. Pedroza, C. Medina-García, and S. Barquera-Cervera, “Hipertensiَn arterial: prevalencia, diagnَstico oportuno, control y tendencias en adultos mexicanos,” Salud Pública de México, vol. 55, supplement 2, pp. S144–S150, 2013. View at Google Scholar
  23. C. J. L. Murray and A. D. Lopez, “On the comparable quantification of health risks: lessons from the global burden of disease study,” Epidemiology, vol. 10, no. 5, pp. 594–605, 1999. View at Google Scholar · View at Scopus
  24. S. Yusuf, S. Reddy, S. Ôunpuu, and S. Anand, “Global burden of cardiovascular diseases. Part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization,” Circulation, vol. 104, no. 22, pp. 2746–2753, 2001. View at Google Scholar · View at Scopus
  25. “Encuesta Nacional de Salud y Nutrición 2006,” Mexican National Institute of Public Health, http://www.insp.mx/ensanut/ensanut2006.pdf.
  26. World Health Organization, Physical Status: The Use and Interpretation of Anthropometry, World Health Organization, Geneva, Switzerland, 1995.
  27. T. G. Pickering, J. E. Hall, L. J. Appel et al., “Recommendations for blood pressure measurement in humans and experimental animals. Part 1. Blood pressure measurement in humans. A statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on high blood pressure research,” Circulation, vol. 111, no. 5, pp. 697–716, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. A. V. Chobanian, G. L. Bakris, H. R. Black et al., “Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure,” Hypertension, vol. 42, no. 6, pp. 1206–1252, 2003. View at Publisher · View at Google Scholar · View at Scopus
  29. G. Mancia, G. De Backer, A. Dominiczak et al., “2007 ESH-ESC Guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC),” Journal of Hypertension, vol. 25, no. 6, pp. 1105–1187, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. G. Mancia, R. Fagard, K. Narkiewicz et al., “2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for theManagement of Arterial Hypertension of the European Society of Hypertension (ESH) andof the European Society of Cardiology (ESC),” European Heart Journal, vol. 34, no. 28, pp. 2159–2219, 2013. View at Publisher · View at Google Scholar
  31. M. Rosas, G. Pastelín, G. Vargas-Alarcón et al., “Comité Institucional de Expertos en Hipertensión Arterial Sistémica. Clinical guidelines for detection, prevention, diagnosis and treatment of systemic arterial hypertension in Mexico (2008),” Archivos de Cardiología de México, vol. 8, supplement 2, p. S2-58-73, 2008. View at Google Scholar
  32. D. G. Kleinbaum, L. L. Kupper, and H. Morgenstern, Epidemiologic Research. Principles and Quantitative Methods, Lifetime Learning, Belmont, Mass, USA, 1982.
  33. B. Rockhill, B. Newman, and C. Weinberg, “Use and misuse of population attributable fractions,” American Journal of Public Health, vol. 88, no. 1, pp. 15–19, 1998. View at Google Scholar · View at Scopus
  34. World Health Organization, International Classification of Diseases. ICD 10th revision, 2012, http://www.who.int/classifications/icd/en/.
  35. A. Graciani, M. C. Zuluaga-Zuluaga, J. R. Banegas, L. M. León-Muñoz, J. J. De La Cruz, and F. Rodríguez-Artalejo, “Cardiovascular mortality attributable to high blood pressure in Spanish population over 50,” Medicina Clinica, vol. 131, no. 4, pp. 125–129, 2008. View at Publisher · View at Google Scholar · View at Scopus
  36. M. M. Ibrahim and A. Damasceno, “Hypertension in developing countries,” The Lancet, vol. 380, no. 9841, pp. 611–619, 2012. View at Publisher · View at Google Scholar
  37. M. Pereira, N. Lunet, A. Azevedo, and H. Barros, “Differences in prevalence, awareness, treatment and control of hypertension between developing and developed countries,” Journal of Hypertension, vol. 27, no. 5, pp. 963–975, 2009. View at Publisher · View at Google Scholar · View at Scopus
  38. H. Arima, F. Barzi, and J. Chalmers, “Mortality patterns in hypertension,” Journal of Hypertension, vol. 29, supplement 1, pp. S3–S7, 2011. View at Publisher · View at Google Scholar · View at Scopus
  39. K. Wolf-Maier, R. S. Cooper, J. R. Banegas et al., “Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States,” Journal of the American Medical Association, vol. 289, no. 18, pp. 2363–2369, 2003. View at Publisher · View at Google Scholar · View at Scopus
  40. M. J. O'Donnell, X. Denis, L. Liu et al., “Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study,” The Lancet, vol. 376, no. 9735, pp. 112–123, 2010. View at Publisher · View at Google Scholar · View at Scopus
  41. Mexico: life expectancy, 2012, http://www.worldlifeexpectancy.com/mexico-life-expectancy.
  42. J. He, D. Gu, J. Chen et al., “Premature deaths attributable to blood pressure in China: a prospective cohort study,” The Lancet, vol. 374, no. 9703, pp. 1765–1772, 2009. View at Publisher · View at Google Scholar · View at Scopus
  43. G. Rose, The Strategy of Preventive Medicine, Oxford University Press, Oxford, UK, 1992.
  44. S. R. Collier and M. J. Landram, “Treatment of prehypertension: lifestyle and/or medication,” Journal of Vascular Health and Risk Management, vol. 8, pp. 613–619, 2012. View at Google Scholar
  45. B. M. Egan, “Achievement of cardiometabolic goals in aware hypertensive patients in Spain. Implications for population health,” Hypertension, vol. 60, pp. 891–893, 2012. View at Publisher · View at Google Scholar
  46. L. A. Alcocer, O. Lozada, G. Fanghänel, L. Sánchez-Reyes, and E. Campos-Franco, “Estratificación del riesgo cardiovascular global. Comparación de los métodos Framingham y SCORE en población mexicana del estudio PRIT,” Cirugía y Cirujanos, vol. 79, no. 2, pp. 168–174, 2011. View at Google Scholar
  47. S. Yusuf, S. Hawken, and S. Ounpuu, “Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study,” The Lancet, vol. 364, no. 937, p. 952, 2004. View at Publisher · View at Google Scholar · View at Scopus